SG11201600334SA - Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof - Google Patents

Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof

Info

Publication number
SG11201600334SA
SG11201600334SA SG11201600334SA SG11201600334SA SG11201600334SA SG 11201600334S A SG11201600334S A SG 11201600334SA SG 11201600334S A SG11201600334S A SG 11201600334SA SG 11201600334S A SG11201600334S A SG 11201600334SA SG 11201600334S A SG11201600334S A SG 11201600334SA
Authority
SG
Singapore
Prior art keywords
fhbp
methods
naturally occurring
binding proteins
occurring factor
Prior art date
Application number
SG11201600334SA
Other languages
English (en)
Inventor
Peter T Beernink
Original Assignee
Children S Hospital & Res Ct Oakland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Children S Hospital & Res Ct Oakland filed Critical Children S Hospital & Res Ct Oakland
Publication of SG11201600334SA publication Critical patent/SG11201600334SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201600334SA 2013-08-02 2014-08-01 Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof SG11201600334SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361861662P 2013-08-02 2013-08-02
PCT/US2014/049465 WO2015017817A1 (en) 2013-08-02 2014-08-01 Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof

Publications (1)

Publication Number Publication Date
SG11201600334SA true SG11201600334SA (en) 2016-02-26

Family

ID=52432473

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201600334SA SG11201600334SA (en) 2013-08-02 2014-08-01 Non-naturally occurring factor h binding proteins (fhbp) and methods of use thereof

Country Status (13)

Country Link
US (1) US9914756B2 (ru)
EP (1) EP3027206A4 (ru)
JP (1) JP2016527278A (ru)
KR (1) KR20160034401A (ru)
CN (1) CN105431167A (ru)
AU (1) AU2014296027A1 (ru)
BR (1) BR112016002150A2 (ru)
CA (1) CA2918547A1 (ru)
EA (1) EA201690056A8 (ru)
IL (1) IL243535A0 (ru)
MX (1) MX2016001412A (ru)
SG (1) SG11201600334SA (ru)
WO (1) WO2015017817A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11066453B2 (en) * 2015-05-18 2021-07-20 Biomvis Srl Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof
KR101865757B1 (ko) 2017-12-06 2018-06-08 김기성 저영향개발형 수처리장치
IL305313A (en) 2021-02-19 2023-10-01 Sanofi Pasteur Recombinant meningococcal B vaccine
WO2024030931A1 (en) 2022-08-03 2024-02-08 Sanofi Pasteur Inc. Adjuvanted immunogenic composition against neisseria meningitidis b
WO2024095289A1 (en) * 2022-11-04 2024-05-10 Techinvention Lifecare Private Limited Mutated factor H binding proteins (fHbp) of Neisseria meningitidis, their compositions and use thereof.

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1210305C (zh) 1998-05-01 2005-07-13 希龙公司 脑膜炎奈瑟球菌抗原和组合物
US20070026021A1 (en) 1998-05-01 2007-02-01 Chiron S.R.I. Neisseria meningitidis antigens and compositions
AU2013206190A1 (en) 1999-11-29 2013-06-27 Novartis Vaccines And Diagnostics S.R.L. Compositions comprising Neisseria meningitidis antigens from serogroups B and C as well as a further antigen
EP1897555B1 (en) 2000-01-17 2014-07-16 Novartis Vaccines and Diagnostics S.r.l. Supplemented OMV vaccine against meningococcus
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
US7785608B2 (en) 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
MXPA05003863A (es) 2002-10-11 2005-09-08 Chiron Srl Vacunas polipeptidicas para amplia proteccion contra lineas hipervirulentas de meningococos.
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741
WO2005064021A2 (en) 2003-12-23 2005-07-14 Glaxosmithkline Biologicals S.A. Vaccine
GB0419408D0 (en) 2004-09-01 2004-10-06 Chiron Srl 741 chimeric polypeptides
PT2682126T (pt) * 2005-01-27 2017-02-28 Children`S Hospital & Res Center At Oakland Vacinas de vesícula com base em agn1870 para proteção de amplo espetro contra doenças causadas por neisseria meningitidis
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
WO2009038889A1 (en) 2007-08-02 2009-03-26 Children's Hospital And Research Center At Oakland Fhbp- and lpxl1-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
US9579372B2 (en) 2008-02-21 2017-02-28 Glaxosmithkline Biologicals Sa Meningococcal fHBP polypeptides
WO2009114485A2 (en) 2008-03-10 2009-09-17 Children's Hospital & Research Center At Oakland Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use
BRPI0917306A2 (pt) 2008-08-27 2016-04-19 Childrens Hosp & Res Ct Oak ensaios com base fator de complemento h para a atividade sérica bacterecida contra neisseria meningitidis
CA2733943A1 (en) * 2008-09-03 2010-03-11 Children's Hospital & Research Center At Oakland Peptides presenting an epitope of an a domain of factor h binding protein and methods of use
IT1394288B1 (it) * 2008-09-12 2012-06-06 Novartis Vaccines & Diagnostic Immunogeni di proteine che legano il fattore h.
GB0819633D0 (en) 2008-10-25 2008-12-03 Isis Innovation Composition
NZ595234A (en) * 2009-03-24 2013-12-20 Novartis Ag Adjuvanting meningococcal factor h binding protein
MX2011011512A (es) 2009-04-30 2012-02-13 Novartis Vaccines & Diagnostic Proteinas de union de factor h quimericas (fhbp) y metodos de uso.
WO2011051893A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
EP4036104B1 (en) 2010-03-30 2024-02-21 Children's Hospital & Research Center at Oakland Factor h binding proteins (fhbp) with altered properties and methods of use thereof
EP2729167B1 (en) 2011-07-07 2018-03-14 De Staat der Nederlanden, vert. door de Minister van VWS A process for detergent-free production of outer membrane vesicles of a gram-negative bacterium
WO2013078223A1 (en) 2011-11-23 2013-05-30 Children's Hospital & Research Center Oakland Anti-factor h binding protein antibodies and methods of use thereof

Also Published As

Publication number Publication date
EP3027206A1 (en) 2016-06-08
EA201690056A8 (ru) 2017-07-31
IL243535A0 (en) 2016-03-31
US9914756B2 (en) 2018-03-13
WO2015017817A1 (en) 2015-02-05
EP3027206A4 (en) 2017-03-08
EA201690056A1 (ru) 2016-07-29
CA2918547A1 (en) 2015-02-05
US20160159865A1 (en) 2016-06-09
KR20160034401A (ko) 2016-03-29
MX2016001412A (es) 2016-10-28
CN105431167A (zh) 2016-03-23
JP2016527278A (ja) 2016-09-08
AU2014296027A1 (en) 2016-02-04
BR112016002150A2 (pt) 2017-09-12

Similar Documents

Publication Publication Date Title
IL280155A (en) Anti- SIGLEC-8 antibodies and methods of using them
IL246921B (en) Binding proteins and their uses
IL290547A (en) Antibodies and methods of use
IL244495A0 (en) Anti-alpha-synuclein antibodies and methods of use
ZA201603308B (en) Novel anti-claudin antibodies and methods of use
IL245946A0 (en) Anti-dpep3 antibodies and methods of use
EP3054973A4 (en) Tm4sf1 binding proteins and methods of using same
HK1225612A1 (zh) 抗ly6e抗體及使用方法
EP3172224A4 (en) Factor h binding protein variants and methods of use thereof
IL243535A0 (en) Unnatural factor h binding proteins and methods of using them
EP2975062A4 (en) PREPARATION AND USE OF DIMERIZED FUSION PROTEIN